KBC Group NV - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 64 filers reported holding CTI BIOPHARMA CORP in Q4 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
KBC Group NV ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q3 2021$42,000
-72.0%
14,325
-76.1%
0.00%–
Q2 2021$150,000–59,894–0.00%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q4 2021.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders